Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Online News Reports.
Press releases published on April 21, 2025
HBT Financial, Inc. Announces First Quarter 2025 Financial Results
GlobeNewswire
·
April 21, 2025
First Quarter Highlights Net income of $19.1 million, or $0.60 per diluted share; return on average assets (“ROAA”) of 1.54%; return on average stockholders' equity (“ROAE”) of 13.95%; and return on average tangible common equity (“ROATCE”)(1) of 16.20% …
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
GlobeNewswire
·
April 21, 2025
NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that new preclinical combination data …
Northland Power Appoints New Chief Financial Officer
GlobeNewswire
·
April 21, 2025
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. (TSX: NPI) (“Northland” or the “Company”) announced today the appointment of Jeff Hart as the Company’s new Chief Financial Officer (CFO), effective May 1, 2025. Mr. Hart brings a wealth of …
BioCryst to Report First Quarter 2025 Financial Results on May 5
GlobeNewswire
·
April 21, 2025
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will host a …
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
GlobeNewswire
·
April 21, 2025
ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 29
GlobeNewswire
·
April 21, 2025
ADDISON, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it …
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
GlobeNewswire
·
April 21, 2025
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first …
USA Rare Earth Announces Date for First Quarter 2025 Results and Conference Call
GlobeNewswire
·
April 21, 2025
STILLWATER, Okla., April 21, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced that it will release financial results for the quarterly period ended March 31, 2025, after U.S. markets close on Wednesday, …
SKYWORKS SOLUTIONS, INC. (NASDAQ: SWKS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Skyworks Solutions, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Skyworks Solutions, Inc. (NASDAQ: SWKS)? Did you purchase your shares between July 30, 2024 and February 5, 2025, inclusive? Did you lose money in your …
ROCKET LAB USA, INC. (NASDAQ: RKLB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rocket Lab USA, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Rocket Lab USA, Inc. (NASDAQ: RKLB)? Did you purchase your shares between November 12, 2024 and February 25, 2025, inclusive? Did you lose money in your …
ENCORE ENERGY CORP. (NASDAQ: EU) DEADLINE ALERT: Bernstein Liebhard LLP Reminds enCore Energy Corp. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of enCore Energy Corp. (NASDAQ: EU)? Did you purchase your shares between March 28, 2024 and March 2, 2025, inclusive? Did you lose money in your investment …
ULTRA CLEAN HOLDINGS, INC. (NASDAQ: UCTT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ultra Clean Holdings, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Ultra Clean Holdings, Inc. (NASDAQ: UCTT)? Did you purchase your shares between May 6, 2024 and February 24, 2025, inclusive? Did you lose money in your …
BIGBEAR.AI HOLDINGS, INC. (NYSE: BBAI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds BigBear.ai Holdings, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of BigBear.ai Holdings, Inc. (NYSE: BBAI)? Did you purchase your shares between March 31, 2022 and March 25, 2025, inclusive? Did you lose money in your …
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Viatris Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Do you, or did you, own shares of Viatris Inc. (NASDAQ: VTRS)? Did you purchase your shares between August 8, 2024 and February 26, 2025, inclusive? Did you lose money in your investment in Viatris Inc.? Do you …
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
GlobeNewswire
·
April 21, 2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …
Cryptocurrency has quietly become the preferred asset reserve for investment, and KSD Miner is very popular among users around the world.
GlobeNewswire
·
April 21, 2025
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- From Change to Big Cash: How to Make $1 Million with $100 in 2025 As times have changed, Will the US tariffs lead to a depreciation of the US dollar? Cryptocurrency has quietly become the preferred asset …
Elixir AI Blazes into Web3 — Achieves 10x Growth on Launch Day
GlobeNewswire
·
April 21, 2025
New York, NY, April 21, 2025 (GLOBE NEWSWIRE) -- In just 24 hours, Elixir AI made waves across the crypto world. Officially launched on April 19, the AI-powered 3D content generation platform saw its native token $ELXAI skyrocket by 10x, signaling early …
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the first quarter 2025 performance and quarterly rebalancing of the OTCQX® …
Apellis Announces Craig Wheeler to Join the Board of Directors
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective …
OMNI-LITE INDUSTRIES REPORTS FOURTH QUARTER AND FISCAL 2024 RESULTS
GlobeNewswire
·
April 21, 2025
❖Record Revenue for Fiscal 2024 of US$15.9 million, a 28% increase over Fiscal 2023 ❖Omni-Lite Achieves Improved Adjusted EBITDA(1) of US$1.6 million in Fiscal 2024 ❖Strong Cash Generation; Improves by US$1.9 million over Fiscal 2023 ❖Bookings for Fiscal …